Australian Luxury Stock News

It is hard to get excited after looking at Adairs' (ASX:ADH) recent performance, when its stock has declined 24% over...

European Lithium (ASX:EUR) is making headlines after launching a share buy-back and selling part of its holding in Critical Metals Corp. These steps have raised substantial capital. Investors are watching how these moves impact the company’s future direction. See our latest analysis for European Lithium. These capital moves come on the heels of a remarkable turnaround in sentiment. The last month’s share price return of 202% and year-to-date return of 644% have captured investor attention...

Key Insights Significantly high institutional ownership implies Vault Minerals' stock price is sensitive to their...

When you buy and hold a stock for the long term, you definitely want it to provide a positive return. Furthermore...

The Australian market is facing a potential decline, influenced by the rising gold prices and weaker-than-expected jobs data, which could keep the indices within the 9,000 range. Amid these conditions, investors often look for opportunities that balance risk and reward, making penny stocks an intriguing option. Although considered a vintage term, penny stocks can still offer significant value when backed by robust financials and solid fundamentals.

Key Insights Given the large stake in the stock by institutions, PEXA Group's stock price might be vulnerable to their...

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...

PolyNovo (ASX:PNV) has just appointed Robert Douglas to its Board of Directors, sparking fresh interest from investors. Douglas’s background in medical device technology and board-level oversight could influence PolyNovo’s next phase of growth. See our latest analysis for PolyNovo. PolyNovo’s appointment of Robert Douglas arrives at a time when the market has been recalibrating its expectations. The stock’s 1-year total shareholder return of -45.5% and year-to-date share price return of...

Key Insights Institutions' substantial holdings in Steadfast Group implies that they have significant influence over...

Key Insights REA Group's estimated fair value is AU$172 based on 2 Stage Free Cash Flow to Equity REA Group's AU$216...

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although...

Key Insights Using the 2 Stage Free Cash Flow to Equity, Trajan Group Holdings fair value estimate is AU$1.65 Trajan...

Stealth Group Holdings (ASX:SGI) has had a great run on the share market with its stock up by a significant 12% over...

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining...

Over the past year, many Catapult Sports Ltd ( ASX:CAT ) insiders sold a significant stake in the company which may...

With a price-to-earnings (or "P/E") ratio of 9.2x Liberty Financial Group Limited ( ASX:LFG ) may be sending very...

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although...

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

PolyNovo (ASX:PNV) has had a rough month with its share price down 20%. However, stock prices are usually driven by a...

The board of Bank of Queensland Limited ( ASX:BOQ ) has announced that it will be paying its dividend of A$0.20 on the...

Meeka Metals recently reported the discovery of thick, high-grade gold zones at Turnberry North, highlighting the potential to expand resources and extend the Stage 1 open pit mine life at the Murchison Gold Project. These intercepts in higher-grade fresh rock below 100 metres, combined with higher current gold prices, prompted new pit design considerations and possible underground development to enhance project economics. We’ll explore how these expansion plans and resource upgrades at...

Clarity Pharmaceuticals (ASX:CU6) has reported that its Co-PSMA trial achieved a key milestone, showing that 64Cu-SAR-bisPSMA identifies significantly more prostate cancer lesions compared to current standard imaging in patients with low PSA levels. See our latest analysis for Clarity Pharmaceuticals. Clarity’s latest clinical achievement has reignited interest, helping the stock stage a strong rebound. The 30-day share price return sits at an impressive 41.0%, though shares are still down...

Audinate Group (ASX:AD8) has caught investor attention following news that Fisher Funds Management Limited is no longer a substantial holder. This development comes alongside the company’s recent issuance and quotation of new securities under its employee incentive scheme. See our latest analysis for Audinate Group. After a sharp climb in the past month, with a 1-month share price return of 38.5%, Audinate Group’s recent announcements around incentive schemes and changing major shareholders...